Clinical trial experts cite trust and regulatory uncertainty as AI barriers

The survey was conducted by the Pistoia Alliance at the Clinical Trials Technology Congress (CTTC) in London. The survey was conducted by the Pistoia Alliance at the Clinical Trials Technology Congress (CTTC) in London. AI is being utilised in many areas of clinical trials, but there are still barriers to its full adoption. Image Credit: khunkornStudio / Shutterstock.com Half of clinical trial experts asked in a recent survey cited trust and regulatory uncertainty as the major barriers to artificial intelligence (AI) adoption. The poll, conducted by The Pistoia Alliance at the Clinical Trials Technology Congress (CTTC) in London, showed that…

Source: Clinical Trials Arena